BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Human Genome Sciences, Inc. Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C

  November 5, 2007

   · 

  9 min read
• Business

  Monsanto Company and Devgen NV Describe New Approach to Insect-Protection

  November 5, 2007

   · 

  3 min read
• Drug Development

  CV Therapeutics, Inc. Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP

  November 5, 2007

   · 

  4 min read
• Schering-Plough Corporation CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment

  November 5, 2007

   · 

  1 min read
• Business

  EpiCept Corporation To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007

  November 5, 2007

   · 

  4 min read
• Business

  Opexa Therapeutics Reports Third Quarter 2007 Financial Results

  November 5, 2007

   · 

  1 min read
• Drug Development

  Insmed Incorporated Announces Initiation of Phase II Clinical Trial with IPLEX(TM) in Myotonic Muscular Dystrophy

  November 5, 2007

   · 

  1 min read
• Drug Development

  Affymax, Inc. Announces Hematide(TM) Successfully Restores Hemoglobin in Patients with Pure Red Cell Aplasia (PRCA)

  November 5, 2007

   · 

  1 min read
• Drug Development

  VIVUS, Inc. Completes Special Protocol Assessment Process for Qnexa Phase 3 Studies

  November 5, 2007

   · 

  1 min read
• Business

  Orexigen Therapeutics, Inc. Schedules November 8, 2007 Webcast Discussion of Third Quarter Financial Results

  November 5, 2007

   · 

  1 min read